<?xml version="1.0" encoding="UTF-8"?>
<ref id="R61">
 <label>61</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <collab>Scottish Medicines Consortium</collab>
  </person-group>. 
  <source>Abiraterone acetate with prednisone or prednisolone for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer in adult men in combination with androgen deprivation therapy [SMC2215</source>, 
  <year>2020</year>.
 </mixed-citation>
</ref>
